Stroke Clinician Interviews the Co-Founders of Phagenesis
Stroke Clinician · 26.06.2026
DOI: 10.59236/sc.v3i2.128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke Clinician, online erschienen am 26.06.2026. Verfasst von Stroke Clinician. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Stroke Clinician recently had the opportunity to interview Drs. Shaheen Hamdy, Chief Scientific Officer and Conor Mulrooney, Chief Operating Officer of Phagenesis. Drs. Hamdy and Mulrooney co-founded Phagenesis, the company that designed and developed the novel Phagenyx System.® Phagenyx is approved for the treatment of neurogenic dysphagia using pharyngeal electrical stimulation.
Zitieren
APA
Clinician, S. (2026). Stroke Clinician Interviews the Co-Founders of Phagenesis. Stroke Clinician. https://doi.org/10.59236/sc.v3i2.128
Vancouver
Clinician S. Stroke Clinician Interviews the Co-Founders of Phagenesis. Stroke Clinician. 2026. doi:10.59236/sc.v3i2.128
BibTeX
@article{Clinician2026,
author = {Clinician, Stroke},
title = {Stroke Clinician Interviews the Co-Founders of Phagenesis},
journal = {Stroke Clinician},
year = {2026},
doi = {10.59236/sc.v3i2.128}
}
EUVIMED